The Oncology Institute, Inc. TOI Change in Accrued Liabilities
Change in Accrued Liabilities at other companies
Other financials
Where this comes from
Reported directly by The Oncology Institute, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about The Oncology Institute, Inc.'s change in accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is The Oncology Institute, Inc.'s change in accrued liabilities?
- The Oncology Institute, Inc. (TOI) reported change in accrued liabilities of $3.92M in Q1 2026.
- How has The Oncology Institute, Inc.'s change in accrued liabilities changed year-over-year?
- The Oncology Institute, Inc.'s change in accrued liabilities increased by 52.6% year-over-year, from $2.57M to $3.92M.
- What does change in accrued liabilities mean?
- Change in accrued expenses and other current liabilities, reflecting timing differences between expense recognition and cash payment.